Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Enablex
Active Ingredient: Darifenacin hydrobromide 17.587mg equivalent to darifenacin 15mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Pfizer Inc, Brooklyn Plant & Laboratories, Brooklyn, New York, United States of America
Product: Enablex
Active Ingredient: Darifenacin hydrobromide 8.929mg equivalent to darifenacin 7.5mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Pfizer Inc, Brooklyn Plant & Laboratories, Brooklyn, New York, United States of America
Product: Klamycin
Active Ingredient: Clarithromycin 250mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Genpharm Inc., Etobicoke, Ontario, Canada
Product: Klamycin
Active Ingredient: Clarithromycin 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Genpharm Inc., Etobicoke, Ontario, Canada
Dated this 19th day of July 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).